By Devika Patel
Knoxville, Tenn., June 29 – bioMerieux placed €200 million of bonds in two tranches on June 15, according to a press release. BNP Paribas and Credit Agricole CIB were the agents.
The company sold €145 million of seven-year notes and €55 million of 10-year notes, with an aggregated annual coupon of 1.61%.
Proceeds will be partly used to refinance the existing €300 million public bond issued in 2013 which matures in October 2020.
bioMerieux is an in vitro diagnostics company located in Marcy-L'etoile, France.
| Issuer: | bioMerieux
|
| Issue: | Bonds
|
| Amount: | €200 million
|
| Coupon: | 1.61% (aggregated annual)
|
| Agents: | BNP Paribas and Credit Agricole CIB
|
| Announcement date: | June 29
|
| Distribution: | Private placement
|
|
|
| Seven-year notes
|
| Amount: | €145 million
|
| Maturity: | Seven years
|
|
|
| 10-year notes
|
| Amount: | €55 million
|
| Maturity: | 10 years
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
